BofA upgraded Stryker to Buy from Neutral with a $315 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SYK:
- Nvidia upgraded, CrowdStrike downgraded: Wall Street’s top analyst calls
- Zimmer Biomet upgraded to Buy from Neutral at BTIG
- Stryker to participate in the 2023 Wells Fargo Securities Healthcare Conference
- Early notable gainers among liquid option names on August 4th
- Stryker sees 2023 adjusted EPS $10.25-$10.45, consensus $10.16